Evaluation of BACE1 Silencing as a Therapy Against Alzheimer Disease: Implications for Lipid Metabolism and Inflammatory Response

doi 10.33612/diss.99684546
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University of Groningen Press

Related search

MiR-124 Acts as a Target for Alzheimer’s Disease by Regulating BACE1

Oncotarget
Oncology
2017English

Coordinated Regulation of Lipid Metabolism and Inflammatory Response in Macrophages

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

miR-15b Represses BACE1 Expression in Sporadic Alzheimer�s Disease

Oncotarget
Oncology
2017English

Targeting the Β Secretase BACE1 for Alzheimer's Disease Therapy

The Lancet Neurology
Neurology
2014English

Frontotemporal Dementia: Implications for Understanding Alzheimer Disease

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2011English

Functional Evaluation of Lipid-Lowering Therapy by Pravastatin Response

Circulation
Cardiovascular MedicinePhysiologyCardiology
1998English

Iron Metabolism and the Inflammatory Response

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Alzheimer Disease and Metabolism: Role of Cholesterol and Membrane Fluidity

2013English

Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

Archives of Neurology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy